During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Eric Wang, Ph.D., received his B.A. in Biochemistry from Harvard College and his Ph.D. from the Harvard-MIT Division of Health Sciences and Technology in Medical Engineering/Medical Physics with a focus on Bioinformatics and Integrative Genomics. He received an NIH Director’s Early Independence Award and launched his independent research group at the Koch Institute for Integrative Cancer Research at MIT. He is currently an Associate Professor in the Center for Neurogenetics and Department of Molecular Genetics and Microbiology at the University of Florida. His lab focuses on repeat expansion diseases, RNA biology, and development of therapeutic approaches. He has received grants from the Chan-Zuckerberg Initiative, Myotonic Dystrophy Foundation, Muscular Dystrophy Association, FARA, HDF, NIH, and DOD. He is also a co-founder of Kate Therapeutics, focused on gene therapies for muscle diseases.